Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients

BACKGROUND: Immune checkpoint blockade has emerged as a highly effective treatment for patients with metastatic melanoma and cutaneous squamous cell carcinoma. Nivolumab blocks the interactions between programmed cell death protein 1 and programmed death ligand 1 allowing for activation of a latent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Trager, Megan H, Coley, Shana M, Dube, Geoffrey, Khan, Shaheer, Ingham, Matthew, Samie, Faramarz H, Geskin, Larisa J, McDonnell, Diana, Brouder, Daniel, Saenger, Yvonne, Carvajal, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279669/
https://ncbi.nlm.nih.gov/pubmed/32503950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000908
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados